Skip to main content

valproic acid

Generic: VALPROIC ACID·Brand: DEPAKENE, STAVZOR, VALPROIC ACID

valproic acid: 3 clinical trials tracked.

valproic acid evidence translation

What we can confirm

3 tracked trials

No verified listed developer

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about valproic acid, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence4 indications · 1 study sponsors
Clinical Trials (3)

Multi-institutional Phase 2/3 Trial of Valproic Acid in Patients With Moderate to Severe Traumatic Brain Injury

NCT07166393·Phase 2/Phase 3
Not yet recruiting

Primary endpoint: Extended Glasgow Outcome Scale (GOS-E)

InterventionalRandomizedtriple432 targetStarted 2027-05Completion 2031-128 sites · United StatesNorthwestern University

A Phase 1, 6-part, Open-label, Fixed-sequence Study to Evaluate the Effects of Lithium, Valproic Acid, and Lamotrigine on the Single-dose Pharmacokinetics of KarXT and Effects of KarXT on the Single-dose Pharmacokinetics of Lithium, Valproic Acid, and Lamotrigine in Healthy Participants

NCT06729970·Phase 1·BMY
Completed

Primary endpoint: Maximum observed plasma concentration (Cmax)

Interventionalopen133 enrolledStarted 2024-12Completion 2026-011 site · United StatesKaruna Therapeutics

A Phase I Trial of Bevacizumab, Temsirolimus Alone and in Combination With Valproic Acid, or Cetuximab in Patients With Advanced Malignancy and Other Indications

NCT01552434·Phase 1
Active, not recruiting

Primary endpoint: Maximum tolerated dose (MTD) of bevacizumab, defined as the dose level below the dose at which 2 of 6 patients experience drug-related dose limiting toxicity (DLT)

Interventionalopen155 targetStarted 2012-10Completion 2026-101 site · United StatesM.D. Anderson Cancer Center